Sourav Sen

Sourav Sen

Auto-generated profile, based on publicly available information

Sourav Sen

Professor & Head, Department of Microbiology, Armed Forces Medical College, Pune, India

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Medical Journal Armed Forces India
Verified
Journal Article
Closed access
KAK.B. Anand
K.B. Anand
SKS. Karade
S. Karade
SSS. Sen
S. Sen
RGR.M. Gupta
R.M. Gupta

1 July 2008 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
MLMahima Lall
Mahima Lall
RGR.M. Gupta
R.M. Gupta
SSSourav Sen
Sourav Sen
KKKetoki Kapila
Ketoki Kapila
STS.P. Tripathy
S.P. Tripathy
RPR.S. Paranjape
R.S. Paranjape
The majority of the HIV drug resistance (HIVDR) testing studies have focused on subtype B virus. The predominance of subtype C in the Indian subcontinent along with greater access to antiretroviral therapy (ART) necessitates studies on HIVDR genotyping. We determined the prevalence of mutations associated with protease inhibitors (PI), nucleoside reverse transcriptase inhibitors (NRTI), and nonnucleoside reverse transcriptase inhibitors (NNRTI) from plasma of 40 antiretroviral drug-naive study participants in Indian HIV-1 pol gene sequences. Of these, 36 sequences belonged to subtype C, two to subtype A1, and two were subtype A1C recombinants. The heterosexual route was the most common route of transmission. Drug resistance-associated mutations were observed in 10% (4/40) of the study participants. The resistance mutation observed in the protease gene was V82A, whereas in the RT gene, M41L, D67N, M184V, and A98G were documented. This is the first study reporting major protease mutations by genotyping in ART-naive individuals from western India.

1 April 2007 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
SSSourav Sen
Sourav Sen
STSrikanth P. Tripathy
Srikanth P. Tripathy
VCVaishali M. Chimanpure
Vaishali M. Chimanpure
APAjit A. Patil
Ajit A. Patil
RBRajani D. Bagul
Rajani D. Bagul
RPRamesh S. Paranjape
Ramesh S. Paranjape
The prevalence of HIV drug resistance (HIVDR) mutations in the HIV protease (PR) and reverse transcriptase (RT) genes was estimated from peripheral blood mononuclear cells (PBMCs) in a study population of 25 antiretroviral (ARV) therapy-naive and 50 ARV-experienced chronically infected patients from Pune city, Maharashtra State, western India. Of the 75 study HIV-1 sequences, 73 belonged to subtype C and 2 to subtype A1. On phylogenetic analysis, the study subtype C sequences sub clustered randomly with different Indian and non-Indian subtype C sequences, emphasizing the HIV-1 subtype C pol gene diversity. The heterosexual route was the most common route of transmission (74.67%). There were no observable HIVDR mutations in ARV-naive patients. The ARV-experienced patients had a history of exposure to nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor combinations. At least one HIVDR mutation in RT was observed in 29 (80.55%) of ARV-experienced patients with evidence of failing therapy. M184V was the most common observed HIVDR mutation. No PR major mutations were observed among ARV-experienced patients. A higher prevalence of proviral HIVDR mutations in PBMCs was associated with irregular adherence to therapy (p < 0.05) and HIV-1 RNA levels > 1000 copies/ml (p < 0.001).

1 October 2007 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
SSSourav Sen
Sourav Sen
STSrikanth P. Tripathy
Srikanth P. Tripathy
APAjit A. Patil
Ajit A. Patil
VCVaishali M. Chimanpure
Vaishali M. Chimanpure
RPRamesh S. Paranjape
Ramesh S. Paranjape
We report one or more HIV resistance mutations in 81.81% of the 33 antiretroviral treatment-experienced study participants with evidence of virologic failure, with M184V being the most commonly observed resistance mutation (69.7%). Two out of four participants with protease inhibitors (PI) experience harbored multiple PI-associated resistance mutations. No resistance mutations were observed in 22 treatment-naive study plasma sequences. All the study pol sequences were subtype C, except one that was subtype A1. On analyzing paired plasma-proviral DNA sequences from 16 treatment-experienced patients, which harbored mutations at positions associated with antiretroviral drug resistance, an 87.5% discordance in reverse transcriptase mutations was seen between the two compartments. Our study highlights the high prevalence of HIV resistance mutations in treatment-experienced patients in Pune, with protease major resistance mutations being reported for the first time from India. The proviral DNA resistance mutation patterns may have an impact on the clinical management of HIV/AIDS.

1 January 2014 in Indian Journal of Pathology and Microbiology
Verified
Journal Article
Open access
SRSarojK. Rath
SarojK. Rath
MMManish Mukherjee
Manish Mukherjee
RKR Kaushik
R Kaushik
SSSourav Sen
Sourav Sen
MKMukesh Kumar
Mukesh Kumar
There has been increasing attention paid in recent years to the possibility that oral bacterial infection, particularly periodontal disease may influence the initiation and or progression of systemic diseases. These studies confirm the observation that heart disease is the most commonly found systemic condition in patients with periodontal disease. Moreover, the literature has also highlighted substantial evidence indicating the presence of Gram-negative periodontal pathogens in atheromatous plaques. This study intends to investigate the possible association between periodontal health and coronary artery disease by evaluating periodontal status, association between the periodontal plaque and coronary atheromatous plaques for presence of micro-organisms such as, Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, and Tannerella forsythia. A case-control study was designed with seven patients who had undergone coronary endarterectomy for cardiovascular disease and 28 controls. The periodontal examination for cases was performed 1 day before vascular surgery and the controls were clinically examined. The atheromatous plaque sample collected during endarterectomy and the intraoral plaque samples were subjected to polymerase chain reaction for identification of A. actinomycetemcomitans, P. gingivalis, P. intermedia and T. forsythia. The presence of periodontal bacteria DNA in coronary atheromatous plaques and sub-gingival plaque samples of the same patients was confirmed by this study. CONCLUSION A correlation was established between putative bacteria contributing to atheromatous plaques and species associated with periodontal disease. One particularly important study to be carried out is the investigation of a possible clinically meaningful reduction in coronary heart disease resulting from the prevention or treatment of periodontal disease.

1 July 2015 in Medical Journal Armed Forces India
Verified
Journal Article
Closed access
IKInam Danish Khan
Inam Danish Khan
MLMahima Lall
Mahima Lall
SSSourav Sen
Sourav Sen
SNS.M. Ninawe
S.M. Ninawe
PCP. Chandola
P. Chandola